Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P36 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Case Reports in Mesothelioma and Thymoma
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 3
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P36.01 - Primary Acinic Cell Carcinoma of Bronchial Ground Origin: A Case Report
00:00 - 00:00 | Presenter: Koichi Hirano
- Abstract
Loading... -
+
P36.02 - A Case of Recurrent Giant Malignant Solitary Fibrous Tumour of the Pleura: An Elephant in the Room?
00:00 - 00:00 | Presenter: Sara Ricciardi
- Abstract
Loading... -
+
P36.03 - Rapidly Progressed Anaplastic Carcinoma in the Anterior Mediastinum Successfully Treated With Gene-Targeted Therapy
00:00 - 00:00 | Presenter: Etsu Chou
- Abstract
Loading...
-
+
P37 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Clinical Research for Pleural Mesothelioma
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 3
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P37.01 - The Results of Multimodal Treatment With Extrapleural Pneumonectomy for Female Epithelioid Malignant Pleural Mesothelioma
00:00 - 00:00 | Presenter: Kazunori Okabe
- Abstract
Loading... -
+
P37.02 - Improving Outcomes in Malignant Pleural Mesothelioma in an Integrated Health System
00:00 - 00:00 | Presenter: Stephanie Ossowski
- Abstract
Loading... -
+
P37.03 - The Epidemic of Malignant Mesothelioma in China: A Prediction of Incidence During 2016-2030
00:00 - 00:00 | Author(s): Yirui Zhai
- Abstract
Loading...
-
+
P38 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Miserenous or Metatstic Lung Tumors
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 2
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P38.01 - p40 and p63 Immunohistochemistry in the Diagnostic Consideration of NUT Carcinoma in the Lung
00:00 - 00:00 | Presenter: Catherine Jordan Roe
- Abstract
Loading... -
+
P38.02 - The Prognostic Role of Neutrophil to Lymphocyte Ratio (NLR) In Lung Metastasectomy for Colorectal Cancer: A Meta-Analysis
00:00 - 00:00 | Presenter: Dimitrios E. Magouliotis
- Abstract
Loading...
-
+
P39 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Thymoma and Mediastinal Tumors
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 5
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P39.01 - Long-Term Outcomes and Characteristics of Unresectable Locally Advanced Thymic Malignancies
00:00 - 00:00 | Presenter: Antonios Sideris
- Abstract
Loading... -
+
P39.02 - Does Neo-Adjuvant Chemotherapy Help in Locally Advanced Thymic Maliganancy?
00:00 - 00:00 | Presenter: SRINIVAS KODAGANUR GOPINATH
- Abstract
Loading... -
+
P39.03 - Primary Mediastinal Germ Cell Tumors: A 15-Years Experience Treatment in Rajavithi Hospital, Thailand
00:00 - 00:00 | Presenter: Kunlatida Maneenil
- Abstract
Loading... -
+
P39.04 - Thymic Epithelial Tumors: The Importance of Invasive Investigation to Adequate Diagnosis
00:00 - 00:00 | Presenter: Paulo Alfredo Casanova Schulze
- Abstract
Loading... -
+
P39.05 - Outcomes of Videothoracoscopic Thymectomy for Treatment Large-Sized Thymomas
00:00 - 00:00 | Presenter: Alexandr Podobed
- Abstract
Loading...
-
+
P40 - Multimodality of Advanced Lung Cancer - Clinical Outcomes
- Type: Posters
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 20
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P40.01 - Maintenance Anlotinib After Induction Therapy With Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Phase 2 Study
00:00 - 00:00 | Presenter: Yongqian Shu
- Abstract
Loading... -
+
P40.02 - Pemetrexed in Advanced-stage Lymphoepithelioma Carcinoma of Lung
00:00 - 00:00 | Presenter: Ri-Qiang Liao
- Abstract
Loading... -
+
P40.03 - Palliative Radiotherapy Decreased Circulating White Blood Cells in Patients With Stage IV Lung Cancer
00:00 - 00:00 | Author(s): Zhibing Liang
- Abstract
Loading... -
+
P40.04 - CNS Adverse Events and Survival in Patients with NSCLC Brain Metastases Treated With Concurrent Radiation and Immunotherapy
00:00 - 00:00 | Presenter: David Riley
- Abstract
Loading... -
+
P40.05 - Radiation-Related Platelet Reduction in Patients With Stage IV Lung Cancer
00:00 - 00:00 | Author(s): Zhibing Liang
- Abstract
Loading... -
+
P40.06 - A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): Jinlin Wang
- Abstract
Loading... -
+
P40.07 - Immunotherapy Toxicity in Lung Cancer & the Impact of Thoracic Radiation Therapy
00:00 - 00:00 | Presenter: Ciani Ellison
- Abstract
Loading... -
+
P40.08 - Bone-Targeted Agents Improve Survival in High Bone Tumor Burden Advanced Non-Small-Cell-Lung Cancer Patients Treated With PD-(L)1 Inhibitors
00:00 - 00:00 | Presenter: Sara Manglaviti
- Abstract
Loading... -
+
P40.09 - Using Real World Data to Identify a Patient Cohort Who Require Prehabilitation to Improve Treatment Rates for Stage 3 NSCLC
00:00 - 00:00 | Presenter: Benjamin W. A. Langley
- Abstract
Loading... -
+
P40.10 - Brain Metastases in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy. Real World Data From a Tertiary Hospital in Spain
00:00 - 00:00 | Presenter: Yago Garitaonaindia
- Abstract
Loading... -
+
P40.11 - Trimodality Therapy Protocol in 144 Superior Sulcus Patients: Good Results Even for Extended Resections and Indications
00:00 - 00:00 | Presenter: Marinus Anne Paul
- Abstract
Loading... -
+
P40.12 - Cardiotoxicity in Lung Cancer Patients Treated With Immune-Checkpoints Inhibitors
00:00 - 00:00 | Presenter: Mariola Blanco Clemente
- Abstract
Loading... -
+
P40.13 - Lung Cancer 5-Year Survival in Croatia - Our Experience
00:00 - 00:00 | Author(s): Fran Seiwerth
- Abstract
Loading... -
+
P40.14 - Efficacy and Safety of Endostar Combined With Camrelizumab and Chemotherapy in Treatment of Advanced NSCLC: A Multi-Center Retrospective Study
00:00 - 00:00 | Presenter: Lin Wu
- Abstract
Loading... -
+
P40.15 - Proton Pump Inhibitors, Prior Therapy and Survival in Patients Treated With Immune Checkpoint Inhibitors for Advanced NSCLC
00:00 - 00:00 | Presenter: Marium Husain
- Abstract
Loading... -
+
P40.16 - Real-World Data and Racial Outcomes for NSCLC in The Chemo-Immunotherapy Era
00:00 - 00:00 | Presenter: Danny Markabawi
- Abstract
Loading... -
+
P40.17 - Palliative Radiotherapy Decreased K+ and Ca2+of the Blood in Patients With Stage IV Lung Cancer
00:00 - 00:00 | Author(s): Wanli Xu
- Abstract
Loading... -
+
P40.18 - Second Line Immunotherapy After Progression on a Different First Line Immunotherapy in Advanced Non-Small Cell Lung Cancer With Focus On Elderly
00:00 - 00:00 | Presenter: Karan Seegobin
- Abstract
Loading... -
+
P40.19 - Efficacy and Toxicity of Third-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): Teresa Beninato
- Abstract
Loading... -
+
P40.20 - Real-Life Analysis of Immunotherapy as the Second or Later Lines Treatment in Patients With Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Sabin Goktas Aydin
- Abstract
Loading...
-
+
P41 - Multimodality of Advanced Lung Cancer - Clinical Trials, Case Report
- Type: Posters
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 2
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P41.01 - Abscopal Response Induced by Thermal Ablation in Advanced NSCLC Patients Failed From Immunotherapy: Preliminary Result From a Phase 2 Trial
00:00 - 00:00 | Presenter: Chuchu Shao
- Abstract
Loading... -
+
P41.02 - Surgery for Small Pulmonary NUT Carcinoma: Case Report
00:00 - 00:00 | Presenter: YUICHI SAITO
- Abstract
Loading...
-
+
P42 - Multimodality of Advanced Lung Cancer - Prognostic Factors
- Type: Posters
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P42.01 - Tumor Size is an Independent Prognostic Factor after Pulmonary Metastasectomy
00:00 - 00:00 | Presenter: Simona Sobrero
- Abstract
Loading... -
+
P42.02 - Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in Resource-Limited Country
00:00 - 00:00 | Presenter: Chawalit Chayangsu
- Abstract
Loading... -
+
P42.03 - Predictive Factors of Response to PD-(L)1 Inhibitors in Patients With Advanced Non-Small Cell Lung and High PD-L1 Expression
00:00 - 00:00 | Presenter: Andrés Barba Joaquín
- Abstract
Loading... -
+
P42.04 - Prognosis Factors in Advanced Lung Cancer Patients Treated With Checkpoint Inhibitor-Based Immunotherapy
00:00 - 00:00 | Presenter: Kan Wu
- Abstract
Loading...
-
+
P43 - Multimodality of Advanced Lung Cancer - Others
- Type: Posters
- Track: Multimodality of Advanced Lung Cancer
- Presentations: 3
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P43.01 - Three-Dimensional Virtual Planning for Nodule Resection in Solid Organs: A Systematic Review and Meta-Analysis
00:00 - 00:00 | Presenter: Paulo Alfredo Casanova Schulze
- Abstract
Loading... -
+
P43.02 - Inconsistencies Within Biomarker Test Reports Provide Opportunities for Future Patient Education
00:00 - 00:00 | Presenter: Nikki Martin
- Abstract
Loading... -
+
P43.03 - LUPA-01: An Observational Study to Monitor Lung Cancer Patients’ Activity and Assess Performance Status through a Wearable Device in Spain
00:00 - 00:00 | Presenter: Santiago Ponce Aix
- Abstract
Loading...
-
+
P44 - Nursing and Allied Health Professionals
- Type: Posters
- Track: Nursing and Allied Health Professionals
- Presentations: 2
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P44.01 - Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC).
00:00 - 00:00 | Presenter: Raena Denise Rhone
- Abstract
Loading... -
+
P44.02 - Prevalence, Onset, and Severity of Renal Impairment With Pemetrexed/Carboplatin +/- Pembrolizumab in Metastatic Non-Squamous NSCLC
00:00 - 00:00 | Presenter: Jennifer Z Miller
- Abstract
Loading...
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P45.01 - Therapeutic effectiveness of Lorlatinib After Alectinib in Japanese Patients With ALK-Positive NSCLC in Real-World
00:00 - 00:00 | Presenter: Yasushi Goto
- Abstract
Loading... -
+
P45.02 - Molecular Profile of Resistance Mutations Post Multiple Lines of Tyrosine Kinase Inhibitors in ALK-Positive Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Moushumi Suryavanshi
- Abstract
Loading... -
+
P45.03 - Tepotinib in Patients with MET exon 14 (METex14) Skipping NSCLC as Identified by Liquid (LBx) or Tissue (TBx) biopsy
00:00 - 00:00 | Presenter: Enriqueta Felip
- Abstract
Loading... -
+
P45.04 - Phase II Study of Brigatinib in ROS1 Positive Non-Small Cell Lung Cancer (NSCLC) Patients Previously Treated with Crizotinib: Barossa Cohort 2
00:00 - 00:00 | Presenter: Jun Sakakibara-Konishi
- Abstract
Loading... -
+
P45.05 - Sequencing of PD-1 Inhibitors and TKIs in Metastatic NSCLC with MET Exon 14 Skipping Mutation May Influence Survival
00:00 - 00:00 | Presenter: Sally CM Lau
- Abstract
Loading... -
+
P45.06 - Overall Survival From a Phase 2 Study of Crizotinib in East Asian Patients With ROS1+ Advanced Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Yi-Long Wu
- Abstract
Loading... -
+
P45.07 - Real-World Clinically-Relevant Toxicities of ALK TKIs in a Cohort of Patients With Advanced/Metastatic ALK+ NSCLC
00:00 - 00:00 | Presenter: Sabine Schmid
- Abstract
Loading... -
+
P45.08 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
00:00 - 00:00 | Presenter: Shun Lu
- Abstract
Loading... -
+
P45.09 - Real-World Sequencing of ALK-TKIs in Advanced Stage ALK-positive NSCLC patients in Canada
00:00 - 00:00 | Presenter: Simren Chotai
- Abstract
Loading... -
+
P45.10 - Effects of ALK Tyrosine Kinase Inhibitors in the Treatment of Metastatic NSCLC: A Systematic Review and Meta-Analysis
00:00 - 00:00 | Presenter: Michela Febbraro
- Abstract
Loading... -
+
P45.11 - Co-occurring CDKN2A/B Alteration Is Associated With Worse Survival Outcomes in Advanced ALK-Positive Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): Luis Lara-Mejía
- Abstract
Loading... -
+
P45.12 - Renal Function Change During Alectinib in ALK Rearranged Non-Small Cell Lung Cancer: A Retrospective Multicentre Analysis
00:00 - 00:00 | Author(s): Daniele Pignataro
- Abstract
Loading... -
+
P45.13 - Efficacy and Safety of Crizotinib in Real-World ROS1-rearranged NSCLC: A Retrospective Canadian Cohort
00:00 - 00:00 | Author(s): Michelle Liane Dean
- Abstract
Loading... -
+
P45.14 - Real-World Experience on Treatment of crizotinib in ALK/ROS1/MET Alterated Non-Small-Cell Lung Cancer Patients in China
00:00 - 00:00 | Presenter: Shaoyu Yang
- Abstract
Loading... -
+
P45.15 - Clinical Outcomes, Long-Term Survival and Toleration With Sequential Therapy of First-Line Crizotinib Followed by Alectinib in ALK+ NSCLC
00:00 - 00:00 | Presenter: Zihua Zou
- Abstract
Loading... -
+
P45.16 - Adverse Event Burden of Oral Tyrosine Kinase Inhibitors in EGFR and ALK Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: David Riley
- Abstract
Loading... -
+
P45.17 - Outcomes of Patients on ALK Inhibitor Therapy in NHS Tayside Scotland UK
00:00 - 00:00 | Author(s): Hannah Lord
- Abstract
Loading... -
+
P45.18 - NSCLC Patients With ALK Gene Rearrangement – Croatian Experience
00:00 - 00:00 | Author(s): Lela Bitar
- Abstract
Loading...
first
prev
